Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
DARE
#4100
Dare Bioscience, Inc. Common Stock
1.430
0
USD
-3.38%
Sector:
Atención Sanitaria
Básica:
USD
Profit Currency:
USD
Rango diario
Rango anual
Cambio diario
-3.38%
Monthly Change
-13.33%
6 month change
-13.33%
Cambio anual
-13.33%
Cierres anteriores
1.480
0
Open
1.440
0
Bid
1.430
0
Ask
1.433
0
Low
1.420
0
High
1.440
0
Volumen
14
Markets
Acciones
Atención Sanitaria
DARE
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
3.94 M
7 M
7.18 M
8.38 M
8.85 M
—
Valuation ratios
Enterprise value
—
—
—
—
11.91 M
61.31 M
Price to earnings ratio
—
—
—
—
-6.5
-25.74
Price to sales ratio
—
—
—
—
2 709.74
2 237.85
Price to cash flow ratio
—
—
—
—
4.91
3.42
Price to book ratio
—
—
—
—
-4.41
-7.55
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-3.63
0.69
0.71
1.42
0.19
-0.07
Return on equity %
23.79
1
2.78
-5.98
-0.68
-1.83
Return on invested capital %
2 336.81
-1 708.34
-718.51
-580.21
-430.8
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-10.56 K
-313.85
-1 101.89
-239.69 K
-153.81 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
10.46 K
309
1 075.54
41.91 K
-125.39 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.91
3.44
1.36
0.86
0.85
2.93
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.2
0.13
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.05
-0
-0
—
—
—
Long term debt to total equity ratio
-0.32
-0
-0.01
—
—
—
Per share metrics
Operating cash flow per share
—
-5.64
-2.57
-5.34
0.63
-0.65
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
10.14
4.92
1.44
1.85
5.4
Net current asset value per share
—
10.85
6.11
2.41
2.17
6.23
Tangible book value per share
—
7.6
1.58
-0.69
-0.71
-3.01
Working capital per share
—
7.7
1.62
-0.4
-0.37
-2.57
Book value per share
—
7.6
1.58
-0.69
-0.71
-3.01
Noticias
Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates
uniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates
Daré Bioscience obtiene autorización de la FDA para ensayo de tratamiento del VPH
Daré Bioscience obtiene autorización de FDA para ensayo de tratamiento de VPH
Daré Bioscience gets FDA clearance for HPV treatment trial
Dare Bioscience launches preferred stock and warrant offering on Nasdaq
Dare Bioscience mantiene calificación de Compra en H.C. Wainwright tras salida de Bayer
Dare Bioscience mantiene calificación de Compra en H.C. Wainwright tras salida de Bayer
Dare Bioscience stock maintains Buy rating at H.C. Wainwright as Bayer exits
Daré Bioscience recuperará los derechos de anticonceptivo sin hormonas de Bayer
Daré Bioscience to regain rights to hormone-free contraceptive from Bayer
Daré Bioscience recibe un pago de subvención de 3,6 millones de dólares para trabajo anticonceptivo